Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists

US8153799B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Timo Flessner · Wuppertal, DE
• Frank-Gerhard Boss · Wuppertal, DE
• Christina Erb · Wiesbaden, DE
• Frank-Thorsten Hafner · Wuppertal, DE
• Katrin Schnizler · Rodenbach, DE
• Dieter Lang · Velbert, DE
• Joachim Luithle · Wülfrath, DE
• Marja Van Kampen · Neu-Isenburg, DE
• Franz-Josef van der Staay · Dronten, NL

Key dates

• Filing date: Aug 30, 2010
• Grant date: Apr 10, 2012
• Expiry date: Aug 30, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel benzothiophene-, benzofuran-, and indole ureas and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning, and/or memory.